Heidy Jimenez

472 total citations
15 papers, 387 citations indexed

About

Heidy Jimenez is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Heidy Jimenez has authored 15 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Heidy Jimenez's work include Alzheimer's disease research and treatments (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Tryptophan and brain disorders (3 papers). Heidy Jimenez is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Tryptophan and brain disorders (3 papers). Heidy Jimenez collaborates with scholars based in United States and Israel. Heidy Jimenez's co-authors include Peter Davies, Cristina d’Abramo, Christopher M. Acker, Jeremy Koppel, Philippe Marambaud, Peter Davies, Valérie Vingtdeux, Leslie R. Adrien, Rachel S. Friedman and Blaine Greenwald and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and Neurobiology of Aging.

In The Last Decade

Heidy Jimenez

15 papers receiving 382 citations

Peers

Heidy Jimenez

PHYSI

PHARM

CMN

NEURO

MB

Rowan Pentz Canada

Bianca T. Corjuc United States

Ivica Granic Netherlands

Diana Thyssen United States

Susann Ludewig Germany

Roger Lefort United States

Meredith A. Chabrier United States

Felipe C. Ribeiro Brazil

Wanda León Canada

Norimichi Nakamura Japan

Rowan Pentz Canada

Heidy Jimenez

182 ×0.7

PHYSI

92 ×0.6

PHARM

125 ×0.9

CMN

90 ×0.7

NEURO

98 ×1.3

MB

Citations per year, relative to Heidy Jimenez Heidy Jimenez (= 1×) peers Rowan Pentz

Countries citing papers authored by Heidy Jimenez

Since Specialization

Citations

This map shows the geographic impact of Heidy Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidy Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidy Jimenez more than expected).

Fields of papers citing papers by Heidy Jimenez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidy Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidy Jimenez. The network helps show where Heidy Jimenez may publish in the future.

Co-authorship network of co-authors of Heidy Jimenez

This figure shows the co-authorship network connecting the top 25 collaborators of Heidy Jimenez. A scholar is included among the top collaborators of Heidy Jimenez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidy Jimenez. Heidy Jimenez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Jimenez, Heidy, Leslie R. Adrien, Eric H. Chang, et al.. (2023). The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [11C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease. Biomedicines. 11(8). 2091–2091. 2 indexed citations

2.

Davidowitz, Eliot J., Patrícia Luciana da Costa Lopez, Heidy Jimenez, et al.. (2023). Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice. PLoS ONE. 18(8). e0286523–e0286523. 6 indexed citations

3.

Jimenez, Heidy, et al.. (2022). Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy. Molecular Medicine. 28(1). 83–83. 4 indexed citations

4.

Jimenez, Heidy, Leslie R. Adrien, Eric H. Chang, et al.. (2022). The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12247–e12247. 5 indexed citations

5.

Davidowitz, Eliot J., Pavan Krishnamurthy, Patricia López, et al.. (2019). In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice. Journal of Alzheimer s Disease. 73(1). 147–161. 13 indexed citations

6.

Moe, James G., Patricia López, Heidy Jimenez, et al.. (2018). P4‐222: IN VIVO EFFICACY OF A SMALL MOLECULE INHIBITOR OF TAU OLIGOMER FORMATION IN HTAU MICE. Alzheimer s & Dementia. 14(7S_Part_29). 1 indexed citations

7.

Koppel, Jeremy, Heidy Jimenez, Leslie R. Adrien, et al.. (2018). Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT‐deleted (DM) tau mouse model. Journal of Neurochemistry. 148(1). 127–135. 14 indexed citations

8.

Koppel, Jeremy, Heidy Jimenez, Leslie R. Adrien, et al.. (2016). Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2(2). 121–130. 28 indexed citations

9.

d’Abramo, Cristina, Christopher M. Acker, Heidy Jimenez, & Peter Davies. (2015). Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies. PLoS ONE. 10(8). e0135774–e0135774. 37 indexed citations

10.

Koppel, Jeremy, Heidy Jimenez, Cristina d’Abramo, et al.. (2014). Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease. Behavioural Brain Research. 275. 27–33. 20 indexed citations

11.

Koppel, Jeremy, Peter Davies, Oscar L. López, et al.. (2014). Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities. Neurobiology of Aging. 35(9). 2021–2028. 45 indexed citations

12.

Koppel, Jeremy, Valérie Vingtdeux, Philippe Marambaud, et al.. (2013). CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease. Molecular Medicine. 19(1). 29–36. 23 indexed citations

13.

Koppel, Jeremy, Valérie Vingtdeux, Philippe Marambaud, et al.. (2013). CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease. Molecular Medicine. 20(1). 29–36. 66 indexed citations

14.

d’Abramo, Cristina, Christopher M. Acker, Heidy Jimenez, & Peter Davies. (2013). Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity. PLoS ONE. 8(4). e62402–e62402. 118 indexed citations

15.

d’Abramo, Cristina, Heidy Jimenez, Christopher M. Acker, & Peter Davies. (2013). P4–028: Tau release from hTau mouse primary neuronal cultures. Alzheimer s & Dementia. 9(4S_Part_18). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact